Explore groundbreaking gene-editing therapy for kidney disease, offering hope to those with polycystic kidney disease.

The widespread use of standard laparoscopic procedures has been constrained by the technical difficulties presented by patients with PKD who have massively enlarged and cystic kidneys.

Dapagliflozin improved eGFR slope in patients with CKD associated with ADPKD, but it resulted in an increase in kidney volume. Dapagliflozin may exert a protective effect on kidney function in ...

U.S.-based researchers examined the burden of imaging in a population of patients with ADPKD, versus that of patients with chronic kidney disease (CKD). People with ADPKD underwent more abdominal ...

A large study of patients in the US Veterans Administration health system revealed that patients with ADPKD had a much higher rates of chronic obstructive pulmonary disease, hypertension, diabetes, ...

Mayo Clinic researchers have developed a promising gene-editing therapy that directly corrects a genetic mutation responsible for autosomal dominant polycystic kidney disease (ADPKD), the most common ...

(StatePoint) This article is sponsored by Otsuka America Pharmaceutical, Inc. Each year, September 4 marks Polycystic Kidney Disease (PKD) Awareness Day, an initiative that aims to increase public ...

A new study examined the records of 4452 Asian patients with ADPKD treated at 2 tertiary-care centers over a period of 15 years. Patients with ADPKD had higher rates of post-transplant diabetes ...

Jul 14, 2025, 5:41am CDT Updated: Jul 14, 2025, 6:26am CDT Courtesy of Renasant Renasant Bio CEO Emily Conley From the San Francisco Business Times. Patients with a life-threatening genetic kidney ...